Cargando…
Trypanothione Reductase: A Viable Chemotherapeutic Target for Antitrypanosomal and Antileishmanial Drug Design
Trypanosomiasis and leishmaniasis are two debilitating disease groups caused by parasites of Trypanosoma and Leishmania spp. and affecting millions of people worldwide. A brief outline of the potential targets for rational drug design against these diseases are presented, with an emphasis placed on...
Autor principal: | Khan, M. Omar F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155241/ https://www.ncbi.nlm.nih.gov/pubmed/21901070 |
Ejemplares similares
-
Investigation of Trypanothione Reductase as a Drug Target in Trypanosoma brucei
por: Spinks, Daniel, et al.
Publicado: (2009) -
Antileishmanial and antitrypanosomal activity of the cutaneous secretion of Siphonops annulatus
por: Pinto, Erika Gracielle, et al.
Publicado: (2014) -
Bioassay-based Corchorus capsularis L. leaf-derived β-sitosterol exerts antileishmanial effects against Leishmania donovani by targeting trypanothione reductase
por: Pramanik, Pijush Kanti, et al.
Publicado: (2020) -
Antitrypanosomal and Antileishmanial Activity of Chalcones and Flavanones from Polygonum salicifolium
por: Zheoat, Ahmed M., et al.
Publicado: (2021) -
Mini review on tricyclic compounds as an inhibitor of trypanothione reductase
por: Kumar, Suresh, et al.
Publicado: (2014)